Skip to main content

Table 1 Demographic details of the COPD and control group

From: Steroid resistance in COPD is associated with impaired molecular chaperone Hsp90 expression by pro-inflammatory lymphocytes

Subjects Controls COPD
No. of subjects 10 10
Age (years) 49 (41–57) 58 (42–64)*
FEV1, % pred 108.4 (91–110) 60.1 (44–96)*
FEV1/% FVC 96 (84–108) 58 (43–73)*
Male/Female 8/6 6/4
  1. Data showing median (range)
  2. Abbreviations: FEV1 forced expiratory volume in 1 s, FVC forced vital capacity; *p < 0.05 compared to controls